Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age - Schwarz, Tino F.; Galaj, Andrzej; Spaczynski, Marek; Wysocki, Jacek; Kaufmann, Andreas M.; Poncelet, Sylviane; Suryakiran, Pemmaraju V.; Folschweiller, Nicolas; Thomas, Florence; Lin, Lan; Struyf, Frank (Cancer medicine (Malden, MA), 2017)
Keywords: Adolescent; Adult; Antibodies, Viral - analysis; Antibodies, Viral - blood; AS04‐HPV‐16/18 vaccine; Bodily Secretions - immunology; Cancer Prevention; Cervix Uteri - immunology; Female; Follow-Up Studies; Human papillomavirus 16 - immunology; Human papillomavirus 18 - immunology; Humans; Middle Aged; older women; Original Research; Papillomavirus Infections - prevention & control; Papillomavirus Vaccines - adverse effects; Papillomavirus Vaccines - immunology; persistence; safety; Uterine Cervical Neoplasms - prevention & control; Vaccination - adverse effects; Vagina - immunology; Young Adult; AS04-HPV-16/18 vaccine; persistence; older women; safety